Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity
Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity
复制标题
DOI:
10.1038/s41590-019-0421-2
复制
发表时间:
2019-08-01
影响因子:
30.5
通讯作者:
Andreasson, Katrin I.
中科院分区:
文献类型:
--
作者:
Liu, Qingkun;Johnson, Emily M.;Andreasson, Katrin I.
Stroke is a multiphasic process in which initial cerebral ischemia is followed by secondary injury from immune responses to ischemic brain components. Here we demonstrate that peripheral CD11b(+)CD45(+) myeloid cells magnify stroke injury via activation of triggering receptor expressed on myeloid cells 1 (TREM1), an amplifier of proinflammatory innate immune responses. TREM1 was induced within hours after stroke peripherally in CD11b(+)CD45(+) cells trafficking to ischemic brain. TREM1 inhibition genetically or pharmacologically improved outcome via protective antioxidant and anti-inflammatory mechanisms. Positron electron tomography imaging using radiolabeled antibody recognizing TREM1 revealed elevated TREM1 expression in spleen and, unexpectedly, in intestine. In the lamina propria, noradrenergic-dependent increases in gut permeability induced TREM1 on inflammatory Ly6C(+)MHCII(+) macrophages, further increasing epithelial permeability and facilitating bacterial translocation across the gut barrier. Thus, following stroke, peripheral TREM1 induction amplifies proinflammatory responses to both brain-derived and intestinal-derived immunogenic components. Critically, targeting this specific innate immune pathway reduces cerebral injury.